Reliv' International (RELV) 10-Q 13 Nov 15 2015 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 02, 2015
Document Information [Line Items]
Entity Registrant Name	RELIV INTERNATIONAL INC
Entity Central Index Key	768,710
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	RELV
Entity Common Stock, Shares Outstanding		12,919,110
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 3,158,965	$ 4,989,392
Accounts receivable, less allowances of $30,200 in 2015 and $26,300 in 2014	84,536	265,530
Accounts and note due from employees and distributors	132,786	121,208
Inventories
Finished goods	4,042,963	3,782,171
Raw materials	1,438,039	1,216,031
Sales aids and promotional materials	138,485	179,263
Total inventories	5,619,487	5,177,465
Refundable income taxes	472,157	257,577
Prepaid expenses and other current assets	771,657	661,038
Deferred income taxes	72,000	61,000
Total current assets	10,311,588	11,533,210
Other assets	272,682	295,929
Cash surrender value of life insurance	2,823,160	2,747,944
Note receivable due from distributor	1,656,449	1,732,982
Deferred income taxes	714,000	686,000
Intangible assets, net	2,723,179	2,925,775
Property, plant and equipment:
Land and land improvements	893,735	883,563
Building	9,951,393	9,966,748
Machinery & equipment	4,350,849	4,355,040
Office equipment	1,223,983	1,235,192
Computer equipment & software	2,337,873	2,505,229
Property, plant, and equipment,Gross	18,757,833	18,945,772
Less: Accumulated depreciation	12,183,081	12,019,802
Net property, plant and equipment	6,574,752	6,925,970
Total assets	25,075,810	26,847,810
Accounts payable and accrued expenses:
Trade accounts payable and other accrued expenses	2,348,308	2,026,198
Distributors' commissions payable	1,588,129	1,753,908
Sales taxes payable	225,884	292,188
Payroll, payroll taxes, and incentive compensation payable	324,539	1,114,763
Total accounts payable and accrued expenses	4,486,860	5,187,057
Current portion of long-term debt	813,560	697,423
Total current liabilities	5,300,420	5,884,480
Noncurrent liabilities:
Revolving line of credit	0	500,000
Long-term debt, less current portion	3,279,589	3,047,267
Other noncurrent liabilities	377,825	418,785
Total noncurrent liabilities	3,657,414	3,966,052
Stockholders' equity:
Preferred stock, par value $.001 per share; 3,000,000 shares authorized; -0- shares issued and outstanding in 2015 and 2014	0	0
Common stock, par value $.001 per share; 30,000,000 authorized; 14,773,083 shares issued and 12,919,110 shares outstanding as of 9/30/2015; 14,673,083 shares issued and 12,819,110 shares outstanding as of 12/31/2014	14,773	14,673
Additional paid-in capital	30,484,480	30,321,598
Accumulated deficit	(8,453,145)	(7,434,595)
Accumulated other comprehensive loss:
Foreign currency translation adjustment	(589,572)	(565,838)
Treasury stock	(5,338,560)	(5,338,560)
Total stockholders' equity	16,117,976	16,997,278
Total liabilities and stockholders' equity	$ 25,075,810	$ 26,847,810

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Allowance for accounts receivable (in dollars)	$ 30,200	$ 26,300
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	3,000,000	3,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	30,000,000	30,000,000
Common stock, shares, issued	14,773,083	14,673,083
Common stock, shares, outstanding	12,919,110	12,819,110

Condensed Consolidated Statemen

Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Product sales	$ 11,250,271	$ 13,206,275	$ 36,401,384	$ 39,867,425
Handling & freight income	944,182	1,108,006	3,072,783	3,387,322
Net sales	12,194,453	14,314,281	39,474,167	43,254,747
Costs and expenses:
Cost of products sold	2,603,167	2,968,139	8,245,871	8,855,401
Distributor royalties and commissions	4,308,647	4,985,450	14,048,971	15,425,704
Selling, general and administrative	5,659,989	6,133,040	18,244,930	19,390,732
Total costs and expenses	12,571,803	14,086,629	40,539,772	43,671,837
Income (loss) from operations	(377,350)	227,652	(1,065,605)	(417,090)
Other income (expense):
Interest income	28,536	31,736	88,991	100,008
Interest expense	(36,814)	(26,054)	(87,502)	(75,689)
Other income / (expense)	(72,373)	(60,372)	(227,434)	(53,983)
Income (loss) before income taxes	(458,001)	172,962	(1,291,550)	(446,754)
Provision (benefit) for income taxes	(169,000)	7,000	(273,000)	(173,000)
Net income (loss)	(289,001)	165,962	(1,018,550)	(273,754)
Other comprehensive income (loss):
Foreign currency translation adjustment	(72,673)	(57,101)	(23,734)	(17,194)
Comprehensive income (loss)	$ (361,674)	$ 108,861	$ (1,042,284)	$ (290,948)
Earnings (loss) per common share - Basic (in dollars per share)	$ (0.02)	$ 0.01	$ (0.08)	$ (0.02)
Weighted average shares (in shares)	12,919,000	12,666,000	12,853,000	12,666,000
Earnings (loss) per common share - Diluted (in dollars per share)	$ (0.02)	$ 0.01	$ (0.08)	$ (0.02)
Weighted average shares (in shares)	12,919,000	12,750,000	12,853,000	12,666,000
Cash dividends declared per common share (in dollars per share)	$ 0	$ 0	$ 0	$ 0

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Operating activities:
Net loss	$ (1,018,550)	$ (273,754)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	758,564	725,584
Stock-based compensation	45,981	36,178
Non-cash life insurance policy accretion	(75,216)	(66,248)
Deferred income taxes	(89,000)	(142,000)
Foreign currency transaction (gain)/loss	98,172	56,195
(Increase) decrease in accounts receivable and accounts due from employees and distributors	163,256	(96,078)
(Increase) decrease in inventories	(585,634)	79,760
(Increase) decrease in refundable income taxes	(214,378)	(234,219)
(Increase) decrease in prepaid expenses and other current assets	(123,423)	(190,337)
(Increase) decrease in other assets	23,247	(11,501)
Increase (decrease) in income taxes payable	0	(199,558)
Increase (decrease) in accounts payable & accrued expenses and other noncurrent liabilities	(86,860)	(403,554)
Net cash used in operating activities	(1,103,841)	(719,532)
Investing activities:
Proceeds from the sale of property, plant and equipment	7,181	1,200
Purchase of property, plant and equipment	(224,719)	(511,227)
Payments received on distributor note receivable	72,088	67,900
Payment of life insurance premiums	0	(252,250)
Net cash used in investing activities	(145,450)	(694,377)
Financing activities:
Proceeds from line of credit borrowings	0	500,000
Repayment of line of credit borrowings	(500,000)	0
Proceeds from term loan borrowings	3,249,501	0
Principal payments on long-term borrowings	(3,334,552)	(508,899)
Net cash used in financing activities	(585,051)	(8,899)
Effect of exchange rate changes on cash and cash equivalents	3,915	(55,391)
Increase (decrease) in cash and cash equivalents	(1,830,427)	(1,478,199)
Cash and cash equivalents at beginning of period	4,989,392	6,656,798
Cash and cash equivalents at end of period	3,158,965	5,178,599
Noncash financing transactions (Note 5):
Issuance of promissory notes	424,000	0
Issuance of company common stock	$ 117,000	$ 0

Accounting Policies

Accounting Policies	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	Note 1-- Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10-Q and reflect all adjustments (which primarily include normal recurring accruals) which management believes are necessary to present fairly the financial position, results of operations and cash flows. These statements, however, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Interim results may not necessarily be indicative of results that may be expected for any other interim period or for the year as a whole. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the year ended December 31, 2014, filed March 24, 2015 with the Securities and Exchange Commission. Certain reclassifications have been made to 2014 amounts within the condensed consolidated statements of cash flows in order to conform to the current year presentation.

Basic and Diluted Earnings (Los

Basic and Diluted Earnings (Loss) per Share	9 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Note 2-- Basic and Diluted Earnings (Loss) per Share Basic earnings (loss) per common share is computed using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed using the weighted average number of common shares and potential dilutive common shares that were outstanding during the period. Potential dilutive common shares consist of outstanding stock options, outstanding stock warrants, and convertible preferred stock. Three months ended September 30 Nine months ended September 30 2015 2014 2015 2014 Numerator: Net income (loss) $ (289,001) $ 165,962 $ (1,018,550) $ (273,754) Denominator: Denominator for basic earnings (loss) per share--weighted average shares 12,919,000 12,666,000 12,853,000 12,666,000 Dilutive effect of employee stock options and other warrants - 84,000 - - Denominator for diluted earnings (loss) per share--adjusted weighted average shares 12,919,000 12,750,000 12,853,000 12,666,000 Basic earnings (loss) per share $ (0.02) $ 0.01 $ (0.08) $ (0.02) Diluted earnings (loss) per share $ (0.02) $ 0.01 $ (0.08) $ (0.02) Options and warrants to purchase 1,897,025 1,087,333 1,075,565

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	Note 3-- Fair Value of Financial Instruments Fair value can be measured using valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those levels: Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets or similar assets or liabilities in markets that are not active. Level 3: Unobservable inputs that reflect the reporting entity's own assumptions. The carrying amount and fair value of the Company's financial instruments are approximately as follows: Description Carrying Value Fair Value Level 1 Level 2 Level 3 September 30, 2015 Long-term debt $ 4,093,149 $ 4,093,149 - $ 4,093,149 - Note receivable 1,757,740 2,020,000 - 2,020,000 - Marketable securities 263,000 263,000 $ 263,000 - - December 31, 2014 Long-term debt $ 4,244,690 $ 4,244,690 - $ 4,244,690 - Note receivable 1,829,827 2,098,000 - 2,098,000 - Marketable securities 284,000 284,000 $ 284,000 - - Long-term debt : The fair value of the Company's term and revolver loans approximate carrying value as these loans were incurred within the current year and have variable market-based interest rates which reset every thirty days. The fair value of the Company's obligation for the acquisition of its lunasin technology license approximates carrying value as this obligation is a zero-interest based obligation discounted utilizing an interest rate factor comparable to the Company's market-based interest rate for its term and revolver loans. The fair value of the Company's notes payable obligations approximates carrying value as these obligations were incurred within the current year and have variable market-based interest rates which reset every ninety days. Note receivable : The Company's note receivable is a variable rate residential mortgage-based financial instrument. An average of published interest rate quotes for a fifteen-year residential jumbo mortgage, a comparable financial instrument, was used to estimate fair value of this note receivable under a discounted cash flow model. Marketable securities : The assets (trading securities) of the Company's Supplemental Executive Retirement Plan are recorded at fair value on a recurring basis, and are presented within Other Assets in the consolidated balance sheets. The carrying value of other financial instruments, including cash, accounts receivable and accounts payable, and accrued liabilities approximate fair value due to their short maturities or variable-rate nature of their respective balances.

Debt

Debt	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Long-term Debt [Text Block]	Note 4-- Debt September 30 December 31 2015 2014 Term loan $ 3,249,501 $ 3,067,442 Revolving line of credit - 500,000 Notes payable 356,787 - Obligation for acquisition of technology license, net 486,861 677,248 4,093,149 4,244,690 Less current portion 813,560 697,423 Total long-term debt $ 3,279,589 $ 3,547,267 Twelve months ending September 30, 2016 $ 813,560 2017 680,008 2018 2,599,581 $ 4,093,149 On September 30, 2015, the Company entered into a series of lending agreements with a new primary lender which include agreements for a $ 3.25 3.5 The new $3.25 million term loan is for a period of three years and requires monthly term loan payments, under a ten-year amortization, consisting of principal of $ 27,080 2.45 The new $3.5 million revolving line of credit agreement accrues interest at a floating interest rate based on the 30-day LIBOR plus 2.25% and has a maturity date of September 30, 2016. As of September 30, 2015, there were no outstanding borrowings on the revolving line of credit. The proceeds from the new $3.25 million term loan were used to pay off the outstanding term loan and revolving line of credit balances, plus accrued interest, due under loan agreements with the Company’s former primary lender. Borrowings under the new lending agreements are secured by all tangible and intangible assets of the Company, a whole life insurance policy on the life of the Company’s Chief Executive Officer, and by a mortgage on the real estate of the Company’s headquarters. The new lending agreements also include a covenant requiring the Company to maintain net tangible worth of not less than $9.5 million. A description of the notes payable is presented in Note 5 -- Long-Term Incentive Compensation Plan.

Long-Term Incentive Compensatio

Long-Term Incentive Compensation Plan	9 Months Ended
	Sep. 30, 2015
Compensation Related Costs [Abstract]
Compensation Related Costs, General [Text Block]	Note 5-- Long-Term Incentive Compensation Plan In July 2010, the Company’s Reliv Europe subsidiary entered into a long-term performance-based incentive compensation agreement with the subsidiary’s senior managers. The valuation of the compensation agreement is an EBITDA-based formula derived from the subsidiary’s financial performance and vests in 20 0 90,800 54,000 186,700 666,000 During the second quarter of 2015, the cumulative incentive amount of $ 756,800 100% vested, and concurrently, each of the subsidiary's senior managers exercised 100% of his/her put option 424,000 100,000 117,000 216,000 The notes payable were issued by the Company to the managers in the second quarter of 2015 and range in length from one to two years with payments of principal and interest due quarterly beginning July 29, 2015. Each of the notes accrue interest at a floating interest rate based on the three-month pound LIBOR rate plus 3 3.57906

Taxes

Taxes	9 Months Ended
	Sep. 30, 2015
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 6-- Taxes The interim financial statement provision for income taxes (benefit) is different from the amounts computed by applying the United States federal statutory income tax rate of 34%. In summary, the reasons for these differences are as follows: Nine months ended September 30 2015 2014 Income taxes (benefit) at U.S. statutory rate $ (439,000) $ (152,000) State income taxes, net of federal benefit 36,000 25,000 Higher / (lower) effective taxes on earnings/losses in certain foreign countries 39,000 (6,000) Foreign corporate income taxes 32,000 8,000 Other, net 59,000 (48,000) $ (273,000) $ (173,000) One of the Company's foreign subsidiaries is presently under local country audit for alleged deficiencies (totaling approximately $ 800,000 20 185,000 136,000 122,000

Recent Accounting Standard Pend

Recent Accounting Standard Pending Adoption	9 Months Ended
	Sep. 30, 2015
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recent Accounting Standards Pending Adoption [Text Block]	Note 7-- Recent Accounting Standard Pending Adoption In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers , which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The ASU will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The standard is effective for fiscal years beginning after December 15, 2017. The new standard permits the use of either the retrospective or modified retrospective transition method. The Company is currently evaluating the effect, if any, that the updated standard will have on its consolidated financial statements and related disclosures, as well its planned transition method. In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern , which requires management to assess, at each annual and interim reporting period, the entity's ability to continue as a going concern within one year from the date the financial statements are issued and provide related disclosures. The new standard will be effective for the Company for the annual reporting period ending December 31, 2016, with early adoption permitted. This standard is not currently expected to have a material effect on the Company's financial statement disclosures upon adoption, though the ultimate impact will be dependent on the Company's financial condition and expected operating outlook at such time.

Accounting Policies (Policies)

Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10-Q and reflect all adjustments (which primarily include normal recurring accruals) which management believes are necessary to present fairly the financial position, results of operations and cash flows. These statements, however, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States. Interim results may not necessarily be indicative of results that may be expected for any other interim period or for the year as a whole. These financial statements should be read in conjunction with the audited consolidated financial statements and footnotes included in the annual report on Form 10-K for the year ended December 31, 2014, filed March 24, 2015 with the Securities and Exchange Commission. Certain reclassifications have been made to 2014 amounts within the condensed consolidated statements of cash flows in order to conform to the current year presentation.

Basic and Diluted Earnings (L14

Basic and Diluted Earnings (Loss) per Share (Tables)	9 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
Schedule of Calculation of Numerator and Denominator in Earnings Per Share [Table Text Block]	The following table sets forth the computation of basic and diluted earnings (loss) per share: Three months ended September 30 Nine months ended September 30 2015 2014 2015 2014 Numerator: Net income (loss) $ (289,001) $ 165,962 $ (1,018,550) $ (273,754) Denominator: Denominator for basic earnings (loss) per share--weighted average shares 12,919,000 12,666,000 12,853,000 12,666,000 Dilutive effect of employee stock options and other warrants - 84,000 - - Denominator for diluted earnings (loss) per share--adjusted weighted average shares 12,919,000 12,750,000 12,853,000 12,666,000 Basic earnings (loss) per share $ (0.02) $ 0.01 $ (0.08) $ (0.02) Diluted earnings (loss) per share $ (0.02) $ 0.01 $ (0.08) $ (0.02)

Fair Value of Financial Instr15

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value, by Balance Sheet Grouping [Table Text Block]	The carrying amount and fair value of the Company's financial instruments are approximately as follows: Description Carrying Value Fair Value Level 1 Level 2 Level 3 September 30, 2015 Long-term debt $ 4,093,149 $ 4,093,149 - $ 4,093,149 - Note receivable 1,757,740 2,020,000 - 2,020,000 - Marketable securities 263,000 263,000 $ 263,000 - - December 31, 2014 Long-term debt $ 4,244,690 $ 4,244,690 - $ 4,244,690 - Note receivable 1,829,827 2,098,000 - 2,098,000 - Marketable securities 284,000 284,000 $ 284,000 - -

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	September 30 December 31 2015 2014 Term loan $ 3,249,501 $ 3,067,442 Revolving line of credit - 500,000 Notes payable 356,787 - Obligation for acquisition of technology license, net 486,861 677,248 4,093,149 4,244,690 Less current portion 813,560 697,423 Total long-term debt $ 3,279,589 $ 3,547,267
Schedule of Maturities of Long-term Debt [Table Text Block]	Estimated maturities of debt at September 30, 2015 are as follows: Twelve months ending September 30, 2016 $ 813,560 2017 680,008 2018 2,599,581 $ 4,093,149

Taxes (Tables)

Taxes (Tables)	9 Months Ended
	Sep. 30, 2015
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	In summary, the reasons for these differences are as follows: Nine months ended September 30 2015 2014 Income taxes (benefit) at U.S. statutory rate $ (439,000) $ (152,000) State income taxes, net of federal benefit 36,000 25,000 Higher / (lower) effective taxes on earnings/losses in certain foreign countries 39,000 (6,000) Foreign corporate income taxes 32,000 8,000 Other, net 59,000 (48,000) $ (273,000) $ (173,000)

Basic and Diluted Earnings (L18

Basic and Diluted Earnings (Loss) per Share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Numerator:
Net income (loss)	$ (289,001)	$ 165,962	$ (1,018,550)	$ (273,754)
Denominator:
Denominator for basic earnings (loss) per share--weighted average shares	12,919,000	12,666,000	12,853,000	12,666,000
Dilutive effect of employee stock options and other warrants	0	84,000	0	0
Denominator for diluted earnings (loss) per share--adjusted weighted average shares	12,919,000	12,750,000	12,853,000	12,666,000
Basic earnings (loss) per share (in dollars per share)	$ (0.02)	$ 0.01	$ (0.08)	$ (0.02)
Diluted earnings (loss) per share (in dollars per share)	$ (0.02)	$ 0.01	$ (0.08)	$ (0.02)

Basic and Diluted Earnings (L19

Basic and Diluted Earnings (Loss) per Share (Details Textual) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share, Amount	1,897,025	1,087,333	1,897,025	1,075,565

Fair Value of Financial Instr20

Fair Value of Financial Instruments (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Fair Value of Financial Instruments [Line Items]
Long-term debt, Carrying Value	$ 4,093,149	$ 4,244,690
Note receivable, Carrying Value	1,757,740	1,829,827
Marketable securities, Carrying Value	263,000	284,000
Long-term debt, Fair Value	4,093,149	4,244,690
Note receivable, Fair Value	2,020,000	2,098,000
Marketable securities, Fair Value	263,000	284,000
Fair Value, Inputs, Level 1 [Member]
Fair Value of Financial Instruments [Line Items]
Long-term debt, Fair Value	0	0
Note receivable, Fair Value	0	0
Marketable securities, Fair Value	263,000	284,000
Fair Value, Inputs, Level 2 [Member]
Fair Value of Financial Instruments [Line Items]
Long-term debt, Fair Value	4,093,149	4,244,690
Note receivable, Fair Value	2,020,000	2,098,000
Marketable securities, Fair Value	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value of Financial Instruments [Line Items]
Long-term debt, Fair Value	0	0
Note receivable, Fair Value	0	0
Marketable securities, Fair Value	$ 0	$ 0

Debt (Details)

Debt (Details) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Carrying Value Of Debt [Line Items]
Term loan	$ 3,249,501	$ 3,067,442
Revolving line of credit	0	500,000
Notes payable	356,787	0
Obligation for acquisition of technology license, net	486,861	677,248
Long-term Debt	4,093,149	4,244,690
Less current portion	813,560	697,423
Total long-term debt	$ 3,279,589	$ 3,547,267

Debt (Details 1)

Debt (Details 1) - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Twelve months ending September 30,
2,016	$ 813,560
2,017	680,008
2,018	2,599,581
Long-term Debt, Total	$ 4,093,149	$ 4,244,690

Debt (Details Textual)

Debt (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Carrying Value Of Debt [Line Items]
Secured Debt	$ 3,249,501	$ 3,067,442
Revolving Credit Facility [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Maturity Date	Sep. 30, 2016
Line of Credit Facility, Maximum Borrowing Capacity	$ 3,500,000
Line of Credit Facility, Interest Rate Description	a floating interest rate based on the 30-day LIBOR plus 2.25%
Secured Debt [Member]
Carrying Value Of Debt [Line Items]
Debt Instrument, Description Of Variable Rate Basis	The term loan's interest rate is based on the 30-day LIBOR plus 2.25%
Debt Instrument, Frequency Of Periodic Payment	monthly
Debt Instrument, Periodic Payment, Principal	$ 27,080
Debt Instrument, Maturity Date	Sep. 30, 2018
Debt Instrument, Term	3 years
Debt Instrument, Restrictive Covenants	The new lending agreements also include a covenant requiring the Company to maintain net tangible worth of not less than $9.5 million.
Debt Instrument, Interest Rate, Stated Percentage	2.45%
Debt Instrument, Amortization Period	10 years

Long-Term Incentive Compensat24

Long-Term Incentive Compensation Plan (Details Textual) - USD ($)	1 Months Ended	3 Months Ended			9 Months Ended
	Apr. 30, 2011	Sep. 30, 2015	Jun. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Long-Term Incentive Compensation Plan [Line Items]
Employee-Related Liabilities, Current		$ 324,539			$ 324,539		$ 1,114,763
Incentive Compensation Plan [Member]
Long-Term Incentive Compensation Plan [Line Items]
Performance Based Incentive Compensation Vest Based On Annual Increment Percentage	20.00%
Employee-Related Liabilities, Current			$ 756,800				$ 666,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights			100% vested, and concurrently, each of the subsidiary's senior managers exercised 100% of his/her put option
Deferred Compensation Arrangement With Individual Shares To Be Issued			100,000
Deferred Compensation Arrangement With Individual Fair Value Of Shares To Be Issued			$ 117,000
Debt Instrument, Description			length from one to two years with payments of principal and interest due quarterly beginning July 29, 2015.
Debt Instrument, Interest Rate, Stated Percentage		3.57906%			3.57906%
Deferred Compensation Arrangement With Individual Distributions Payments			$ 216,000
Increase (Decrease) in Deferred Compensation		$ 0		$ 54,000	$ 90,800	$ 186,700
Incentive Compensation Plan [Member] | London Interbank Offered Rate (LIBOR) [Member]
Long-Term Incentive Compensation Plan [Line Items]
Debt Instrument, Description of Variable Rate Basis			three-month pound LIBOR rate plus 3%
Debt Instrument, Basis Spread on Variable Rate			3.00%
Incentive Compensation Plan [Member] | Notes Payable, Other Payables [Member]
Long-Term Incentive Compensation Plan [Line Items]
Deferred Compensation Arrangement With Individual Distributions Payments			$ 424,000

Taxes (Details)

Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Taxes [Line Items]
Income taxes (benefit) at U.S. statutory rate			$ (439,000)	$ (152,000)
State income taxes, net of federal benefit			36,000	25,000
Higher / (lower) effective taxes on earnings/losses in certain foreign countries			39,000	(6,000)
Foreign corporate income taxes			32,000	8,000
Other, net			59,000	(48,000)
Income Tax Expense (Benefit), Total	$ (169,000)	$ 7,000	$ (273,000)	$ (173,000)

Taxes (Details Textual)

Taxes (Details Textual) - USD ($)	9 Months Ended	36 Months Ended
	Sep. 30, 2015	Dec. 31, 2006	Dec. 31, 2014	Dec. 31, 2010
Taxes [Line Items]
Effective Income Tax Rate Reconciliation, Percent, Total	34.00%
Vat And Withholding Taxes		$ 800,000
Interest Penalty Percentage		20.00%
Management Estimated Reserve For Tax	$ 136,000		$ 122,000	$ 185,000